Clinical Trials Directory

Trials / Completed

CompletedNCT01970917

Effect of Olixia Pure® Eye Drops on Tear Film Thickness in Healthy Subjects

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
16 (actual)
Sponsor
Medical University of Vienna · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Dry eye syndrome (DES) is a common ocular disease, especially in the elderly population. Despite many treatment approaches, instillation of topical lubricants remains the mainstay of therapy. However, most of the topical lubricants available are not very well characterized and data about efficacy is sparse. The aim of the present project is to investigate the effect of topically administered Olixia pure® eye drops on tear film thickness in healthy subjects. Tear film thickness will be determined using ultra high-resolution optical coherence tomography (OCT). Measurements will be performed before instillation of the eye drops and every 10 minutes after instillation for one hour. One eye will receive Olixia pure® eye drops, the fellow eye will receive physiologic saline solution as placebo control. The study eye will be chosen randomly.

Conditions

Interventions

TypeNameDescription
DEVICEOlixia pure eye drops
DEVICEPlacebo0.9% physiological saline solution

Timeline

Start date
2013-10-01
Primary completion
2013-11-01
Completion
2013-11-01
First posted
2013-10-28
Last updated
2013-11-27

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT01970917. Inclusion in this directory is not an endorsement.